Newsletter Sign Up

StopAfib.org

Newsletter Signup
Get in Rhythm. Stay in Rhythm.™ Atrial Fibrillation Patient Conference. Aug 4-6, 2017, in Dallas, TX
Get in Rhythm. Stay in Rhythm.™ Atrial Fibrillation Patient Conference. Aug 4-6, 2017, in Dallas, TX

CONVERGE Trial Will Study Convergent Procedure for Treatment of Persistent Atrial Fibrillation

CONVERGE clinical trial will compare the Convergent Procedure with catheter ablation for treating persistent afib

By Mellanie True Hills and Melissa Moss

Published June 26, 2014 (Updated April 7, 2017)

  • Summary:  The CONVERGE trial will study the convergent procedure for persistent atrial fibrillation.
  • Reading time: 1–2 minutes

AtriCure (previously nContact) has launched the CONVERGE (Convergence Of Epicardial And Endocardial Radiofrequency Ablation For The Treatment Of Symptomatic Persistent AF) study for treatment of persistent atrial fibrillation. This trial will compare the convergent procedure with traditional catheter ablation.

The Convergent Procedure combines surgery and catheter ablation in a single procedure in a single setting. The minimally-invasive surgical procedure works on the outside of the heart, and accesses it through a small abdominal incision.

To learn more about the study, including who is eligible and what centers are participating, see:

Back to News

Last Modified June 26, 2014

Get Started Learning About Atrial Fibrillation

Afib Community

Blog Forum

Locate Help

Afib services near you

USA Locations International Locations List Your Afib Services

We comply with the HONcode standard for trustworthy health information: verify here.

Newsletter Sign Up